X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs NATCO PHARMA - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD NATCO PHARMA ORCHID PHARMA LTD/
NATCO PHARMA
 
P/E (TTM) x -0.5 24.4 - View Chart
P/BV x 0.4 18.5 2.0% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ORCHID PHARMA LTD   NATCO PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
NATCO PHARMA
Mar-14
ORCHID PHARMA LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs194877 22.1%   
Low Rs35424 8.3%   
Sales per share (Unadj.) Rs276.5223.4 123.7%  
Earnings per share (Unadj.) Rs-79.231.1 -255.0%  
Cash flow per share (Unadj.) Rs-43.540.3 -107.9%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs53.9219.5 24.6%  
Shares outstanding (eoy) m70.4533.07 213.0%   
Bonus/Rights/Conversions ESOPPA-  
Price / Sales ratio x0.42.9 14.2%   
Avg P/E ratio x-1.420.9 -6.9%  
P/CF ratio (eoy) x-2.616.1 -16.3%  
Price / Book Value ratio x2.13.0 71.7%  
Dividend payout %016.1 0.0%   
Avg Mkt Cap Rs m8,06721,504 37.5%   
No. of employees `0002.8NA-   
Total wages/salary Rs m2,5271,128 224.1%   
Avg. sales/employee Rs Th6,956.1NM-  
Avg. wages/employee Rs Th902.5NM-  
Avg. net profit/employee Rs Th-1,993.0NM-  
INCOME DATA
Net Sales Rs m19,4777,389 263.6%  
Other income Rs m407167 243.7%   
Total revenues Rs m19,8847,556 263.2%   
Gross profit Rs m1,1031,793 61.5%  
Depreciation Rs m2,519304 827.6%   
Interest Rs m5,227366 1,427.3%   
Profit before tax Rs m-6,2361,290 -483.5%   
Minority Interest Rs m2046 42.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125309 -40.6%   
Profit after tax Rs m-5,5801,027 -543.1%  
Gross profit margin %5.724.3 23.3%  
Effective tax rate %2.023.9 8.4%   
Net profit margin %-28.713.9 -206.1%  
BALANCE SHEET DATA
Current assets Rs m11,0143,681 299.2%   
Current liabilities Rs m32,0603,123 1,026.7%   
Net working cap to sales %-108.17.6 -1,429.4%  
Current ratio x0.31.2 29.1%  
Inventory Days Days9589 106.0%  
Debtors Days Days3459 57.2%  
Net fixed assets Rs m29,4407,685 383.1%   
Share capital Rs m705331 213.0%   
"Free" reserves Rs m2,0436,670 30.6%   
Net worth Rs m3,8007,259 52.3%   
Long term debt Rs m9,018955 944.4%   
Total assets Rs m46,51011,957 389.0%  
Interest coverage x-0.24.5 -4.3%   
Debt to equity ratio x2.40.1 1,804.0%  
Sales to assets ratio x0.40.6 67.8%   
Return on assets %-0.811.7 -6.5%  
Return on equity %-146.914.2 -1,037.6%  
Return on capital %-3.720.7 -18.0%  
Exports to sales %37.939.4 96.3%   
Imports to sales %22.65.7 396.8%   
Exports (fob) Rs m7,3782,908 253.7%   
Imports (cif) Rs m4,406421 1,046.1%   
Fx inflow Rs m7,5133,445 218.1%   
Fx outflow Rs m5,649703 803.8%   
Net fx Rs m1,8652,743 68.0%   
CASH FLOW
From Operations Rs m1,6821,440 116.8%  
From Investments Rs m-9,860-1,089 905.3%  
From Financial Activity Rs m6,644-353 -1,883.7%  
Net Cashflow Rs m-1,535-1 103,020.1%  

Share Holding

Indian Promoters % 32.3 52.0 62.1%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 4.6 7.8 58.7%  
FIIs % 3.3 16.6 19.8%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 26.0 212.7%  
Shareholders   84,811 25,395 334.0%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   MERCK LTD  CIPLA  TORRENT PHARMA  ALEMBIC LTD  WYETH LTD  

Compare ORCHID PHARMA LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Marginally Down; Tata Steel Top Loser(09:30 am)

Asian stocks rose in morning trade on Monday, after the US's S&P 500 extended its winning streak on Friday to six days. Markets in the Greater China region remain closed for the Lunar New Year holiday.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Feb 19, 2018 11:45 AM

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - PIRAMAL ENTERPRISES COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS